WASHINGTON, D.C. (WUSA) -- A vaccine for pancreatic cancer could be available in the next couple of years. This is welcome news since this is one of the most deadly forms of cancer.
The results of a phase 2 trial at the University Hospital of Case Medical Centers in Cleveland presented on Tuesday shows 62 percent of patients who had the cancer removed and used the vaccine stayed cancer free for at least a year. The overall year-long survival rate for the patients was 86 percent.
The final phase 3 research is already underway, as scientists try to get the vaccine out to the public. The findings were presented Tuesday at the Annual Meeting of the Society for Surgery of the Alimentary Tract in San Diego. This is part of the Digestive Disease Week events.
Pancreatic cancer is the 4th leading cause of cancer in the US. It kills over 35,000 Americans a year. Long-term survival is less than 5 percent.